atrastenan
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for atrastenan, covering 2023-06-22 to 2023-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer [Phase 2]